Arhgap18-KO Mouse
Common Name
Arhgap18-KO
제품 ID
S-KO-14236
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-73910-Arhgap18-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Arhgap18-KO Mouse (카탈로그 번호 S-KO-14236)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Arhgap18-KO
품종 계통계통 ID
KOCMP-73910-Arhgap18-B6J-VA
유전자명
제품 ID
S-KO-14236
유전자 별칭
4833419J07Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 10
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000039557
NCBI 전사체 ID
NM_176837
타겟 영역
Exon 2~4
유효 영역 크기
~9.0 kb
유전자 연구 개요
ARHGAP18, a member of the RhoGAP gene family, functions as a GTPase-activating protein for RhoA. It cycles RhoA between an active, GTP-bound state and an inactive, GDP-bound state, thereby regulating the actin cytoskeleton. This regulation is crucial for multiple biological processes such as cell shape determination, spreading, motility, angiogenesis, and endothelial cell alignment [3,6,7].
In triple-negative breast cancer (TNBC), ARHGAP18 deletion increased RhoA activation but reduced growth, migration, and metastatic capacity. Higher ARHGAP18 levels in human breast tumors were associated with worse survival outcomes [1]. In hepatocellular carcinoma (HCC), ARHGAP18 overexpression promoted cell proliferation, migration, and invasion [4]. In angiogenesis, loss of ARHGAP18 promoted EC hypersprouting and enhanced tumor vascularization. It acts on RhoC and is important for reaffirming stable EC junctions [2]. In endothelial cells, depletion of ARHGAP18 inhibited alignment in the direction of flow, promoted an inflammatory phenotype, and in double-mutant mice with apolipoprotein E deficiency, led to early-onset atherosclerosis [5]. In thoracic aortic aneurysm (TAA), Arhgap18 global knockout mice exhibited a synthetic, proteolytic, and proinflammatory smooth muscle phenotype and developed TAA more frequently and severely [8].
In conclusion, ARHGAP18 plays essential roles in various biological processes and diseases. Through gene knockout models in mice and other loss-of-function experiments, its roles in cancer metastasis, angiogenesis, endothelial cell function, and aortic aneurysm formation have been revealed. These findings contribute to understanding the mechanisms underlying these disease conditions and may provide potential therapeutic targets.
References:
1. Humphries, Brock, Wang, Zhishan, Li, Yunfei, Jiang, Yiguo, Yang, Chengfeng. 2017. ARHGAP18 Downregulation by miR-200b Suppresses Metastasis of Triple-Negative Breast Cancer by Enhancing Activation of RhoA. In Cancer research, 77, 4051-4064. doi:10.1158/0008-5472.CAN-16-3141. https://pubmed.ncbi.nlm.nih.gov/28619708/
2. Chang, Garry H K, Lay, Angelina J, Ting, Ka Ka, Vadas, Mathew A, Gamble, Jennifer R. . ARHGAP18: an endogenous inhibitor of angiogenesis, limiting tip formation and stabilizing junctions. In Small GTPases, 5, 1-15. doi:10.4161/21541248.2014.975002. https://pubmed.ncbi.nlm.nih.gov/25425145/
3. Lombardo, Andrew T, Mitchell, Cameron A R, Zaman, Riasat, McDermitt, David J, Bretscher, Anthony. 2024. ARHGAP18-ezrin functions as an autoregulatory module for RhoA in the assembly of distinct actin-based structures. In eLife, 13, . doi:10.7554/eLife.83526. https://pubmed.ncbi.nlm.nih.gov/38193818/
4. Chen, Ping, Liu, Xiaomeng, Liu, Yayue, Bao, Xu, Wu, Qiang. 2023. ARHGAP18 is Upregulated by Transcription Factor GATA1 Promotes the Proliferation and Invasion in Hepatocellular Carcinoma. In Applied biochemistry and biotechnology, 196, 679-689. doi:10.1007/s12010-023-04459-0. https://pubmed.ncbi.nlm.nih.gov/37171759/
5. Lay, Angelina J, Coleman, Paul R, Formaz-Preston, Ann, Vadas, Mathew A, Gamble, Jennifer R. . ARHGAP18: A Flow-Responsive Gene That Regulates Endothelial Cell Alignment and Protects Against Atherosclerosis. In Journal of the American Heart Association, 8, e010057. doi:10.1161/JAHA.118.010057. https://pubmed.ncbi.nlm.nih.gov/30630384/
6. Maeda, Masao, Hasegawa, Hitoki, Hyodo, Toshinori, Hamaguchi, Michinari, Senga, Takeshi. 2011. ARHGAP18, a GTPase-activating protein for RhoA, controls cell shape, spreading, and motility. In Molecular biology of the cell, 22, 3840-52. doi:10.1091/mbc.E11-04-0364. https://pubmed.ncbi.nlm.nih.gov/21865595/
7. Coleman, Paul R, Lay, Angelina J, Ting, Ka Ka, Vadas, Mathew A, Gamble, Jennifer R. 2020. YAP and the RhoC regulator ARHGAP18, are required to mediate flow-dependent endothelial cell alignment. In Cell communication and signaling : CCS, 18, 18. doi:10.1186/s12964-020-0511-7. https://pubmed.ncbi.nlm.nih.gov/32013974/
8. Liu, Renjing, Lo, Lisa, Lay, Angelina J, Vadas, Mathew A, Gamble, Jennifer R. 2017. ARHGAP18 Protects Against Thoracic Aortic Aneurysm Formation by Mitigating the Synthetic and Proinflammatory Smooth Muscle Cell Phenotype. In Circulation research, 121, 512-524. doi:10.1161/CIRCRESAHA.117.310692. https://pubmed.ncbi.nlm.nih.gov/28701309/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
